Table 3

Cluster associations with COPD-related measures and COPD SNPs in training and validation data for core feature set cluster solution, k = 4

TrainingValidation
C2: OR (95% CI)C3: OR (95% CI)C4: OR (95% CI)C2: OR (95% CI)C3: OR (95% CI)C4: OR (95% CI)
Exacerbations2.27 (1.97 to 2.61)***3.16 (2.82 to 3.55)***8.93 (7.97 to 10.01)***2.17 (1.90 to 2.49)***2.66 (2.38 to 2.98)***7.80 (7.00 to 8.70)***
MMRC2.81 (2.57 to 3.07)***3.39 (3.14 to 3.66)***10.88 (10.00 to 11.83)***2.02 (2.01 to 2.40)***3.00 (2.78 to 3.23)***10.07 (9.26 to 10.94)***
BODE3.37 (3.06 to 3.70)***4.63 (4.27 to 5.02)***66.52 (60.06 to 73.67)***2.62 (2.38 to 2.88)***4.23 (3.90 to 4.58)***52.64 (47.62 to 58.19)***
Hospitalisations/ER visits4.07 (3.34 to 4.95)***5.05 (4.24 to 6.01)***11.82 (9.98 to 14.00)***3.05 (2.53 to 3.68)***4.13 (3.52 to 4.86)***8.03 (6.86 to 9.39)***
rs7671167 (FAM13A)0.95 (0.87 to 1.04)NS0.87 (0.81 to 0.93)*0.84 (0.78 to 0.91)*1.01 (0.92 to 1.10)NS0.89 (0.83 to 0.95)NS0.91 (0.85 to 0.98)NS
rs1980057 (HHIP)0.64 (0.58 to 0.70)***0.92 (0.85 to 0.98)NS0.79 (0.73 to 0.85)***0.80 (0.73 to 0.87)*1.09 (1.01 to 1.17)NS0.74 (0.69 to 0.80)***
rs13180 (Chr15q25)0.82 (0.75 to 0.90)*1.04 (0.96 to 1.11)NS0.82 (0.76 to 0.88)**0.72 (0.66 to 0.79)***0.99 (0.92 to 1.07)NS0.82 (0.76 to 0.88)**
rs8034191 (Chr15q25)1.33 (1.21 to 1.46)**1.03 (0.96 to 1.11)NS1.50 (1.39 to 1.61)***1.30 (1.19 to 1.43)**0.89 (0.83 to 0.96)NS1.17 (1.09 to 1.26)*
rs7937 (Chr 19q13)1.30 (1.18 to 1.42)**1.16 (1.08 to 1.24)*1.20 (1.12 to 1.29)*1.08 (0.99 to 1.18)NS1.06 (0.99 to 1.14)NS1.46 (1.36 to 1.57)***
  • Effect sizes represent OR from logistic regression or proportional odds logistic regression in the case of exacerbations, MMRC score and BODE index.

  • In all instances, cluster 1 (ie, the cluster with the highest mean FEV1% of predicted) serves as the reference.

  • Effect allele for rs7671167 = C, rs1980057 = T, rs13180 = C, rs8034191=C, rs7937=T.

  • *0.01<p≤0.05; **0.001<p≤0.01; ***p≤0.001, NS p>0.05.